Evidence map›Paper›PMID 41996464›Full record

ArticlePloS one2026

Ultra-high dose rate electron FLASH beam irradiation using a modified clinical linear accelerator.

Gyu-Seok Cho, Kyo-Tae Kim, Soon-Sung Lee, Jeong-Hwan Kim, Dong-Han Lee, Hong-Suk Chang, Sang-Hyoun Choi, Kum-Bae Kim, Tae-Keun Yang, Dong-Hyun An and 8 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Gyu-Seok ChoRadiation Therapy Technology and Standards, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.ORCID https://orcid.org/0000-0003-1263-250X
Kyo-Tae KimRadiation Therapy Technology and Standards, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Soon-Sung LeeRadiation Therapy Technology and Standards, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Jeong-Hwan KimRadiation Therapy Technology and Standards, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Dong-Han LeeDepartment of Cyberknife, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.
Hong-Suk ChangRadiation Therapy Technology and Standards, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Sang-Hyoun ChoiRadiation Therapy Technology and Standards, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Kum-Bae KimRadiation Therapy Technology and Standards, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Tae-Keun YangRadiation Therapy Technology and Standards, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Dong-Hyun AnRadiation Therapy Technology and Standards, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Geun-Beom KimRadiation Therapy Technology and Standards, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Kun-Uk KangRadiation Therapy Technology and Standards, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Jin-Kyu KangDepartment of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.
Eun-Ji KimDepartment of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.
Eun-Kyung PaikDepartment of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.
Mi-Sook KimDepartment of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.
Won-Il JangDepartment of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.ORCID https://orcid.org/0000-0002-5279-3087
Kwang-Mo YangDepartment of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FLASH radiation therapy reduced radiation-induced damage to normal tissue, compared to conventional radiation therapy, and active studies have been undertaken worldwide. While a number of preclinical studies have revealed the effectiveness of this novel radiotherapy, the biological effects have not been fully elucidated. Here, we implemented ultra-high dose-rate FLASH beam irradiation through machine modifications of the core components of an existing clinical linear accelerator, to build a database containing information related to the biological effects of the FLASH beam. We established a protocol that enables a quick conversion between the CONV and FLASH modes of an existing clinical linear accelerator. At 100 cm source-to-surface distance in 10 cm × 10 cm applicator conditions, we achieved FLASH electron beam irradiation characterized by 9.49 MeV mean energy, effective field size (95% iso-dose distribution) ∅ 39.9 mm, and maximum dose rate of 339.1 Gy/s. Irradiation of an elliptical Gaussian beam with flatness of 12.7% and symmetry of 0.3% was confirmed. Furthermore, most of the required preclinical conditions were satisfied. However, although the pulse dose value obtained from the protocol is expected to meet the requirement of 1 Gy/pulse, this result was not confirmed in this study, and further investigation is required.

Indexed as

ElectronsParticle AcceleratorsAnimalsDose-Response Relationship, RadiationHumansRadiotherapy Dosage

Identifiers

PMID41996464
PMCPMC13089894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.